WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT06967805 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

BIOLOGICAL: MTX-463
OTHER: Placebo

Sponsor

Mediar Therapeutics